• OPEN AN ACCOUNT
Indian Indices
Sensex
73,895.74 315.20
( 0.43%)
Global Indices
Nasdaq
51,839.66 468.68
(0.91%)
Dow Jones
7,763.25 38.12
(0.49%)
Hang Seng
66,308.10 794.11
(1.21%)
Nikkei 225
10,694.57 14.58
(0.14%)
Forex
USD-INR
95.89 0.16
(0.16%)
EUR-INR
109.08 -0.12
(-0.11%)
GBP-INR
126.82 -0.30
(-0.24%)
JPY-INR
0.60 0.00
(-0.20%)

EQUITY - MARKET SCREENER

Concord Biotech Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
543960
INE338H01029
193.0629905
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CONCORDBIO
53.5
15213.29
EPS(TTM)
Face Value()
Div & Yield %
27.18
1
0.52
 

Oswal Leasing reports standalone net loss of Rs 0.02 crore in the March 2026 quarter
May 23,2026
Net loss of Oswal Leasing reported to Rs 0.02 crore in the quarter ended March 2026. There were no net profit/loss reported during the previous quarter ended March 2025. Sales declined 25.00% to Rs 0.03 crore in the quarter ended March 2026 as against Rs 0.04 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 0.05 crore in the year ended March 2026 as against net loss of Rs 0.02 crore during the previous year ended March 2025. Sales declined 6.67% to Rs 0.14 crore in the year ended March 2026 as against Rs 0.15 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales0.030.04 -25 0.140.15 -7
OPM %-66.670 --35.71-13.33 -
PBDT-0.020 0 -0.05-0.02 -150
PBT-0.020 0 -0.05-0.02 -150
NP-0.020 0 -0.05-0.02 -150